New review reveals how non-genomic estrogen signaling undermines treatment response and fuels tumor progression Hormone receptor–positive breast ...
Paper defines the mechanism by which COUR Nanoparticles induce antigen-specific immune toleranceCHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company ...
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced that the China National Intellectual Property ...
What the research is about Shigellosis is an infectious disease that causes severe abdominal pain, diarrhea, and bloody ...
DelveInsight's DUB Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, addressable patient ...
The China National Intellectual Property Administration approved the patent covering Hoth’s HT-KIT technology, which is ...
By Dr. Liji Thomas, MD By analyzing microRNAs in blood, saliva, and vaginal mucus, researchers uncover fluid-specific molecular patterns that could inform future noninvasive diagnostics for ...
Hepatocellular carcinoma (HCC), characterized by high aggressiveness and recurrence, poses a significant global health challenge. The interplay between the tumour microenvironment and exogenous ...
A research team led by Professor Yuan Li at Nanjing Medical University published a research paper entitled "A Cigarette ...
Cirrhotic cardiomyopathy (CCM) is a significant complication of cirrhosis, but its progression and underlying mechanisms ...